Skip to main content
  1. Home
  2. Emerging Tech
  3. Health & Fitness
  4. News

Surgery-free ‘nasal airway remodeler’ boosts airflow in congested patients’ noses

Add as a preferred source on Google
Patients Can Breathe Easy: New Procedure Helps Improve Nasal Airflow

Tens of millions of Americans suffer from sinus pain and inflammation due to obstruction of the nasal cavity. This can cause chronic congestion, fatigue, and difficulty breathing. While it’s possible to temporarily alleviate some of these symptoms with medication, in the long term, the only proven solution is for a patient to undergo nasal surgery. That could be about to change, however.

Recommended Videos

A Sunnyvale, California-based startup called Aerin Medical has developed a noninvasive device to help solve this problem, which it can reportedly do with both minimal discomfort to the patient and, just as importantly, long-lasting results.

“This device helps to reshape the nasal valve region in order to improve airflow,” Ohio State University’s Dr. Brad Otto, leader of an ongoing clinical trial, told Digital Trends. “For many people, the nasal valve is a very important region in the perception of normal, good airflow. This solves the problem of nasal obstruction for those people whose nasal valve contributes to the obstruction.”

Ohio State University

The Vivaer Nasal Airway Remodeling device works by applying radio frequency energy to cartilage in the patient’s nose. Before the procedure is performed, computed tomography (CT) scans are taken to reveal exactly how the airflow through the nasal cavity is being affected by the blockage. The wand-like nasal airway remodeling device then targets energy toward the affected areas. No anesthetic is needed, and there’s no sustained recovery period, as would be the case after invasive surgery.

“We have performed the procedure on nine patients,” Otto said. “We plan to perform the procedure on a total of 15 patients for the purposes of this study. We do not have any publishable results related to the study at this time. The trial is aimed at determining the effectiveness of the procedure in improving nasal obstruction, and is also aimed at examining the effects the procedure has on nasal airflow, as determined by computational fluid dynamics.”

If you want to be among those in the clinical trial, you can get in touch to put yourself forward as a test subject. With the promise of greatly improved breathing, there’s not a whole lot for you to lose — and that includes your nose cartilage.

Luke Dormehl
I'm a UK-based tech writer covering Cool Tech at Digital Trends. I've also written for Fast Company, Wired, the Guardian…
Students who use AI every day may be falling behind, while moderate users pull ahead
New global testing data suggests more AI in the classroom isn't automatically better.
Logo, Text

I assumed more AI access might help students learn faster. However, a new OECD study dispels that misconception for me and everyone else who gave their children a paid version of AI chatbots, thinking it would help them through their educational journey. 

According to PISA 2025 data from 760,000 students in 91 countries, students who use AI daily score meaningfully worse on standardized tests than their peers. The full picture is more complicated than a simple ban would fix.

Read more
XPENG just put its humanoid robot on the production line, and it walked itself out
IRON clocks in for its first shift
XPENG Iron

XPENG’s humanoid robot has officially joined the workforce, and it even got an employee badge. The Chinese automaker announced on September 8 that its next-generation IRON had completed assembly and autonomously walked off its newly commissioned humanoid robot production line in Guangzhou.

CEO He Xiaopeng then pinned a staff badge onto the robot, symbolically welcoming it to the XPENG team. It is a charming little ceremony for a machine that the company hopes will eventually become a regular part of everyday life. XPENG is moving IRON beyond R&D prototypes toward production-line manufacturing, applying the quality-control systems and manufacturing experience it has developed through its electric vehicle business.

Read more
An AI-designed drug might help slow aging, but we’re not there yet
The results hint at a possible anti-aging effect, but there’s still a long way to go before we know what it means.
medical test tubes

Rentosertib, a drug Insilico Medicine designed almost entirely using AI, was created to treat idiopathic pulmonary fibrosis, a disease that scars and stiffens the lungs over time. But fighting lung disease was only half the plan from the start.

According to a new study published in Nature Biotechnology, the drug's target was chosen specifically because it overlaps heavily with the biology of aging, and the whole trial was designed to test whether treating the lungs could also mean turning back the body's biological clock.

Read more